Their new study aims to give budding industry a framework for understanding how fusion can be profitable.
Healthcare Certificate Graduates Urged to Harness New Skills to Address Industry Challenges
The study has broad implications for investors, regulators, policymakers, and clinicians
New books about the future of AI, working remotely, the COVID-19 vaccine, and how to build the perfect portfolio.
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
A new book by two MIT economists Jonathan Gruber and Simon Johnson presents an ambitious plan to boost public funding in scientific research and development in dozens of communities around the country
For a company's conflict management system to be successful, it needs to support the people who report those conflicts.
A new MIT Sloan School of Management study finds that the ratings investors rely on are quietly optimized for stability by MSCI, the world’s largest ESG ratings provider.
The 2026 MIT delta v Demo Day showcased startup innovations in biotechnology, healthcare, AI, cybersecurity, robotics, finance, and manufacturing.
